Aspirin vs. P2Y12 Inhibitor for Long-Term Therapy Upon Completion of DAPT Post-PCI
Presenter
Dominick J. Angiolillo, M.D., FSCAI, UF Health Jacksonville, Jacksonville, FL
Dominick J. Angiolillo, M.D., FSCAI, UF Health Jacksonville, Jacksonville, FL
Learning Objectives:
- Describe long-term bleeding and ischemia risk post-PCI.
- Compare long-term outcomes post-PCI when using aspirin vs. P2Y12 inhibitor mono-therapy.
- Compare the various P2Y12 inhibitors when used as long-term mono-therapy post-PCI.
Keywords: Coronary, Drug-eluting Stent (DES) and Pharmacotherapy